Europe PDX Models Market– Industry Trends and Forecast to 2025

  • Healthcare IT
  • Published Report
  • Jul 2018
  • Europe
  • 118 Pages
  • No of Tables: 22
  • No of Figures: 63

Europe PDX Models Market, By Type (Mice Models, Rat Models), Tumor Type (Respiratory Tumor Models, Urological Tumor Models, Gastrointestinal Tumor Models, Hematological Tumor Models, Gynecological Tumor Models, Others), Application (Preclinical Drug Development & Oncology Research, Biomarker Analysis), End User (Contract Research Organization, Academic & Research Institutions, Pharmaceutical & Biotechnology Companies), Geography (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe) – Industry Trends and Forecast to 2025

Europe PDX Models Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization. However, due to high cost of PDX models and strict regulations with respect to the utilization of animal models in cancer research are hindering the market growth.

Market Segmentation: Europe PDX Models Market

  • The Europe PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share 2025.
  • The Europe PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.
  • The Europe PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.
  • The Europe PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.
  • Based on geography, the market is segmented into 11 geographical countries

    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Switzerland
    • Netherlands
    • Turkey
    • Belgium
    • Russia
    • Rest of Europe.

Key Drivers: Europe PDX Models Market

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

Key Points: Europe PDX Models Market

Charles River is going to dominate the Europe PDX models market following with Crown Bioscience Inc., Champion Oncology, Inc., Oncodesign, Wuxi Apptec, The Jackson Laboratory, Horizon Discovery Group plc, Pharma test Services Ltd, Aragen Bioscience (Subsidiary of GVK Biosciences Private Limited), MI Bioresearch Inc., EUROPDX, Creative Animodel, Urolead, Xentech, Hera BioLabs and EPO BERLIN-BUCH GMBH among others.

  • The mice models segment is dominating the Europe PDX models market.
  • Respiratory tumor models segment is expected to grow with the highest CAGR of 15.7% in the forecast period 2018 to 2025.

SKU-

LIST OF TABLES EUROPE PDX MODELS MARKET

TABLE 1 EUROPE PDX MODELS MARKET, BY TYPE, 2016– 2025, (USD MILLION)

TABLE 2 EUROPE MICE MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 3 EUROPE RAT MODELS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 4 EUROPE PDX MODELS MARKET, BY TUMOR TYPE, 2016– 2025 (USD MILLION)

TABLE 5 EUROPE GASTROINTESTINAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 6 EUROPE GYNECOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 7 EUROPE RESPIRATORY TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 8 EUROPE UROLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 9 EUROPE HEMATOLOGICAL TUMOR MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 10 EUROPE OTHERS TUMOR TYPES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 11 EUROPE PDX MODELS MARKET, BY APPLICATION, 2016– 2025 (USD MILLION)

TABLE 12 EUROPE PRECLINICAL DRUG DEVELOPMENT AND ONCOLOGY RESEARCH IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 13 EUROPE BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 14 EUROPE PDX MODELS MARKET, BY END USER, 2016– 2025, (USD MILLION)

TABLE 15 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN PDX MODEL MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 16 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 17 EUROPE ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELA MARKET, BY REGION, 2016-2025, (USD MILLION)

TABLE 18 EUROPE PDX MODELS MARKET, BY COUNTRY , 2016 – 2025 (USD MILLION)

TABLE 19 EUROPE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 20 EUROPE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 21 EUROPE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 22 EUROPE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 23 GERMANY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 24 GERMANY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 25 GERMANY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 26 GERMANY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 27 FRANCE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 28 FRANCE PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 29 FRANCE PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 30 FRANCE PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 31 U.K. PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 32 U.K. PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 33 U.K. PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 34 U.K. PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 35 ITALY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 36 ITALY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 37 ITALY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 38 ITALY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 39 SPAIN PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 40 SPAIN PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 41 SPAIN PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 42 SPAIN PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 43 SWITZERLAND PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 44 SWITZERLAND PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 45 SWITZERLAND PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 46 SWITZERLAND PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 47 NETHERLANDS PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 48 NETHERLANDS PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 49 NETHERLANDS PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 50 NETHERLANDS PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 51 TURKEY PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 52 TURKEY PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 53 TURKEY PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 54 TURKEY PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 55 BELGIUM PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 56 BELGIUM PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 57 BELGIUM PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 58 BELGIUM PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 59 RUSSIA PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

TABLE 60 RUSSIA PDX MODELS MARKET, BY TUMOR TYPE, 2016 – 2025, (USD MILLION)

TABLE 61 RUSSIA PDX MODELS MARKET, BY APPLICATION, 2016 – 2025, (USD MILLION)

TABLE 62 RUSSIA PDX MODELS MARKET, BY END USER, 2016 – 2025, (USD MILLION)

TABLE 63 REST OF EUROPE PDX MODELS MARKET, BY TYPE, 2016 – 2025, (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE